翰宇药业：利拉鲁肽制剂及多种GLP-1原料药签约订单金额合计近6亿元
2024-05-02 07:55:44
5月2日讯，翰宇药业今日在互动平台表示，截至今日，公司利拉鲁肽制剂及多种GLP-1原料药签约订单金额合计近6亿元，部分订单已陆续出货中；制剂生产基地获得欧盟GMP认证和美国cGMP认证，原料药生产基地通过了澳大利亚TGA-GMP认证和美国cGMP认证。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
欧元区4月制造业PMI终值 45.7，预期45.6，前值45.6。Next article：
德国4月制造业PMI终值 42.5，预期42.2，前值42.2。
